A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
about
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancerHepatotoxicity Secondary to ChemotherapyStereotactic body radiation therapy for liver metastasesCancer concepts and principles: primer for the interventional oncologist-part IILiver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapyNoradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.Neo-adjuvant therapy improves resectability rates for colorectal liver metastases.Interstitial laser hyperthermia: a new approach for treating liver metastasesA phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Evolution in the treatment of metastatic colorectal carcinoma of the liverClinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention.Hepatic artery chemotherapy in the management of colorectal metastases.Review article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.Chemotherapy and other systemic therapies for hepatocellular carcinoma and liver metastases.Recent and ongoing clinical trials for treating colorectal cancer.Treatment options for colorectal liver metastases.Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?Hepatic arterial chemotherapy for metastatic colorectal carcinoma.Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain.Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Transcatheter intraarterial therapies: rationale and overviewHepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.Hemorrhage associated with hepatic artery pseudoaneurysms after regional chemotherapy with floxuridine: case report.The role of aggressive regional therapy for colorectal liver metastases.Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort.A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.Intravital microscopic research of microembolization with degradable starch microspheres.Regional chemotherapy for colorectal hepatic metastases using degradable starch microspheres. A review.Advances in therapeutics for liver metastasis from colorectal cancer.Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.Advances in regional chemotherapy of the liver.Minimally invasive evaluation and treatment of colorectal liver metastases.
P2860
Q24240109-D8F26CB7-764F-4A06-81FB-F5371E41701CQ26861560-E14D3C1A-0FBF-418D-BE4E-09B6A6D87965Q27008308-20D34C5E-000D-4403-A1F4-3BCD3BA7F924Q27010961-A42C98E2-25BA-4356-AD33-E274EBAE4845Q28346035-BED13788-7692-4D0E-B172-B6798B4E6956Q30674169-9A0E16BD-C3EB-4709-B2D0-9A488567998DQ30988365-E3D609AC-2C17-4248-BD0C-20F6BCFB4F65Q33203912-7EEEB12D-CBE9-40D1-B502-01641A4CDA2FQ33390290-4C90D878-CF79-4F12-B7F7-9D5C992C97D6Q33411190-5AC5F7B2-7D58-43E0-A833-CDF21B108701Q33502056-80B7DEEA-B4AD-41D7-8D90-6F7B01D55757Q33679628-E5F51544-D745-4E1B-B131-0AC6CA518B1FQ33868416-1D8F6BE6-9F71-4AD5-8EDC-2D08AE0307BAQ33874670-D64FE4D5-008E-4CCB-9004-CE586C494574Q33960732-5C5B9051-00D7-415A-A70C-FE245BB59702Q34116771-B1A926E0-9EC0-4459-8328-18E582D08A6FQ34374142-89842FC5-6DD8-427C-8547-ADAEFA8CD9ECQ34534003-C3D54AB6-5E6A-4CFE-B9AB-12A8A6830EAAQ34563336-3886B042-7B19-4AC8-A050-D5A8C3F781F3Q34660903-72CC77E4-E552-4A26-B8C0-9EAA23704B8CQ35531003-B016F539-E518-48E7-BADF-4BBC9A0111BBQ35643367-F1C13E61-AF7B-4603-90BF-021848AFF9B1Q35925520-706FE855-542F-49B5-8686-93EB19C35C07Q35977692-6FA806F5-AEE9-4BCA-B6B8-CA4796C1B6F9Q36065977-785A6EB4-426C-434E-A370-BB5B4D5EC3CCQ36067527-1FD19B3D-52B6-403E-856C-C0878777DF95Q36083102-297302C7-DFD1-4B06-9DCB-8D6F532D1A56Q36097254-A4321098-0D2A-4256-A11C-17938F843A0EQ36104314-F06C48F3-2AEE-4326-8956-E632FB755355Q36409952-12E28DBC-AF58-4E8A-80CA-57F57E0B002AQ36782377-30A072EA-6AF1-498E-9CE1-E86E4D0C9F67Q36946762-13C7D8B6-8734-4C4D-8F0A-25F00680CC3CQ37042430-063BCD97-4E80-458F-B0F7-63D699C1C968Q37254998-A83BD977-AB5A-4952-B3D0-F4058F83312FQ37353624-D815B6B4-5CAB-46F2-AA0C-02FBB2D20CB5Q37723546-A1D87D2E-D8A9-4CBD-B4A8-E9CE0835296EQ37821285-BA97721D-B4DB-4AF2-806F-823C10A8A97CQ37821853-689C1900-3384-498C-9EFF-088A8C94AD31Q37867126-70C696C5-24C0-4C8A-B154-5FC682340EC8Q37982074-C8813581-4DEF-45B5-B8A6-5208C07A3877
P2860
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
A prospective randomized trial ...... f colorectal liver metastases.
@ast
A prospective randomized trial ...... f colorectal liver metastases.
@en
A prospective randomized trial ...... f colorectal liver metastases.
@nl
type
label
A prospective randomized trial ...... f colorectal liver metastases.
@ast
A prospective randomized trial ...... f colorectal liver metastases.
@en
A prospective randomized trial ...... f colorectal liver metastases.
@nl
prefLabel
A prospective randomized trial ...... f colorectal liver metastases.
@ast
A prospective randomized trial ...... f colorectal liver metastases.
@en
A prospective randomized trial ...... f colorectal liver metastases.
@nl
P2093
P2860
P1433
P1476
A prospective randomized trial ...... f colorectal liver metastases.
@en
P2093
Schneider PD
Steinberg SM
Sugarbaker PH
P2860
P304
P356
10.1097/00000658-198712000-00001
P407
P577
1987-12-01T00:00:00Z